Not logged in Share Save
Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case Series Chow, Kar Ven Cavan; Conduit, Ciara; O'Haire, Sophie; Kuchel, Anna; Wong, Shirley; Grimison, Peter; Weickhardt, Andrew; Pranavan, Ganes; Lynam, James; Bastick, Patricia; Goh, Jeffrey; Sengupta, Shomik; Smith, Annabel; Liow, Elizabeth; Campbell, David; Wong, Ming; Zlatic, Kristina; Gibbs, Peter; Tran, Ben; Gan, Chun Loo Share Save
Share Save
Share Save
Characteristics and outcomes among patients with delayed orchidectomy for advanced germ cell tumours Ngo, Patrick; Ahmadi, Nariman; Ferguson, Peter; Conduit, Ciara; O'Haire, Sophie; Kuchel, Anna; Pranavan, Ganes; Weickhardt, Andrew; Tran, Ben; Grimison, Peter Share Save
Determination of the phase 2 dose of AU-007, an AI-designed human monoclonal antibody that redirects IL-2 to T-effector cells Wyant, T.; McKean, M.; Rasco, D.; Haydon, A. M.; Powderly, J. D.; Weickhardt, A. J.; Ahern, E. S.; De Souza, P.; Ganju, V.; Hu-Lieskovan, S.; Kichenadasse, G.; Tang, J.; Richards, L.; Knickerbocker, A.; Amit, I.; Ofran, Y.; Vasselli, J. Share Save
TYRA-300, an oral, FGFR3-selective inhibitor: Preliminary pharmacokinetic and pharmacodynamic analysis from SURF301, the multicenter open-label phase 1/2 study of TYRA-300 in advanced urothelial carcinoma and other solid tumors with activating FGFR3 alterations Loriot, Y.; Zhang, A.; Hansen, A.; Mantia, C.; Boni, V.; Weickhardt, A.; Yu, E. Y.; Robert, M.; Iyer, G.; Murtha, A.; Owens, S.; Suttle, B.; Vandekerkhove, G.; Wyatt, A.; Gammon, G.; Burn, T.; Tran, B. Share Save
Preliminary safety and anti-tumor activity of TYRA-300, a highly selective FGFR3 inhibitor, in participants with advanced solid tumors with activating FGFR3 mutations/fusions (SURF301) Tran, B.; Boni, A.; Hansen, A.; Boni, V.; Mantia, C.; Yu, E.; Weickhardt, A.; Robert, M.; Gupta, S.; Necchi, A.; Morales-Barrera, R.; Hoimes, C.; Berlin, J.; Iyer, G.; Millward, M.; Burn, T.; Lihou, C.; Gammon, G.; Rosenberg, J.; Loriot, Y. Share Save
A Multicenter, Open-label Phase 1/2 Study of TYRA 300 in Advanced Urothelial Carcinoma and Other Solid Tumors with Activating FGFR3 Gene Alterations (SURF301) Zhang, A.; Boni, V.; Hanson, A.; Mantia, C.; Weickhardt, A.; Yu, E.; Gupta, S.; Robert, M.; Iyer, G.; Millward, M.; Morales-Barrera, R.; Hoimes, C.; Berlin, J.; Mittal, K.; Hill, A.; Racca, F.; Pouessel, D.; Lihou, C.; Tran, B.; Loriot, Y. Share Save
UpFrontPSMA: A randomised phase II study of sequential 177Lu-PSMA-617 and docetaxel (D) versus docetaxel in metastatic hormone-sensitive prostate cancer (mHSPC) Azad, A. A.; Bressel, M.; Tan, H.; Voskoboynik, M.; Suder, A.; Weickhardt, A. J.; Guminski, A.; Francis, R. J.; Saghebi, J.; Dhiantravan, N.; Joshua, A.; Emmett, L.; Murphy, D.; Hsiao, E.; Lee, S. T.; Pattison, D. A.; Nadebaum, D.; Kirkwood, I. D.; Hofman, M. S. Share Save
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502) Weickhardt, Andrew; Foroudi, Farshad; Lawrentschuk, Nathan; Xie, Jing; Sidhom, Mark; Pal, Abhijit; Grimison, Peter; Zhang, Alison; Ng, Siobhan; Tang, Colin; Hovey, Elizabeth; Chen, Colin; Hruby, George; Guminski, Alexander; McJannett, Margaret; Conduit, Ciara; Tran, Ben; Davis, Ian D.; Hayne, Dickon Share Save
A phase 1 study of LY4101174 (ETx-22), an antibody-drug conjugate targeting nectin-4, in patients with advanced or metastatic urothelial cancer and other solid tumors (trial in progress) Rosenberg, Jonathan; Sabatier, Renaud; Viceneux, Armelle; Rouge, Thibault De la Motte; Champiat, Stephane; Lebellec, Loic; Barthelemy, Philippe; Sonpavde, Guru; Gao, Xin; Niglio, Scot; Zhang, Tian; Gedye, Craig; Galsky, Matthew; Milowsky, Matthew; Reimers, Melissa; Weickhardt, Andrew; Grande, Enrique; Castellano, Daniel E.; Bilen, Mehmet; Patnaik, Amita; Zerbib, Robert; Balbas, Minna; Xu, Xiaojian; Aptaker, Kaitlyn; Balar, Arjun V.; Awada, Ahmad H. Share Save
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies Lin, Chia-Chi; Garralda, Elena; Schoeffski, Patrick; Hong, David S.; Siu, Lillian L.; Martin, Miguel; Maur, Michela; Hui, Rina; Soo, Ross A.; Chiu, Joanne; Zhang, Tian; Ma, Brigette; Kyi, Chrisann; Tan, Daniel S. W.; Cassier, Philippe A.; Sarantopoulos, John; Weickhardt, Andrew; Carvajal, Richard D.; Spratlin, Jennifer; Esaki, Taito; Rolland, Frederic; Akerley, Wallace; Deschler-Baier, Barbara; Rispoli, Lawrence; Samant, Tanay S.; Chowdhury, Niladri Roy; Gusenleitner, Daniel; Kwak, Eunice L.; Askoxylakis, Vasileios; De Braud, Filippo Share Save
Preliminary pharmacodynamic evaluation of AU-007 in phase 1 dose escalation trial in patients with advanced solid tumors Wyant, Timothy; Frentzas, Sophia; Ahern, Elizabeth; Weickhardt, Andrew; Haydon, Andrew; Powderly, John; Rasco, Drew; McKean, Meredith; De Souza, Paul; Tang, Jenny; Richards, Lori; Knckerbocker, Aron; Ofran, Yanay; Amit, Inbar; Vasselli, James Share Save
Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort Fernando, Michael; Anton, Angelyn; Weickhardt, Andrew; Azad, Arun A.; Uccellini, Anthony; Brown, Stephen; Wong, Shirley; Parente, Phillip; Shapiro, Julia; Liow, Elizabeth; Torres, Javier; Goh, Jeffrey; Parnis, Francis; Steer, Christopher; Warren, Mark; Gibbs, Peter; Tran, Ben Share Save
The PD-1-and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial Luke, Jason J.; Patel, Manish R.; Blumenschein, George R.; Hamilton, Erika; Chmielowski, Bartosz; Ulahannan, Susanna V.; Connolly, Roisin M.; Santa-Maria, Cesar A.; Wang, Jie; Bahadur, Shakeela W.; Weickhardt, Andrew; Asch, Adam S.; Mallesara, Girish; Clingan, Philip; Dlugosz-Danecka, Monika; Tomaszewska-Kiecana, Monika; Pylypenko, Halyna; Hamad, Nada; Kindler, Hedy L.; Sumrow, Bradley J.; Kaminker, Patrick; Chen, Francine Z.; Zhang, Xiaoyu; Shah, Kalpana; Smith, Douglas H.; De Costa, Anushka; Li, Jonathan; Li, Hua; Sun, Jichao; Moore, Paul A. Share Save
A phase I/II, first-in-human, open-label, dose-escalation study of TAK-186, an EGFR 3 CD3ε COBRA T cell engager, in adult patients with unresectable, locally advanced, or metastatic solid tumors Weickhardt, A. J.; Frentzas, S.; Lemech, C.; Srimani, J.; Yin, J.; Trepicchio, W. L.; Gorgun, C.; Kichenadasse, G. Share Save
Enzalutamide and 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer (mCRPC): A randomised, phase II trial: ENZA-p (ANZUP 1901) Emmett, L.; Subramaniam, S.; Crumbaker, M.; Joshua, A. M.; Weickhardt, A. J.; Lee, S. T.; Ng, S.; Francis, R. J.; Goh, J. C. H.; Pattison, D. A.; Tan, H.; Kirkwood, I. D.; Sandhu, S. K.; Nguyen, A.; Gedye, C.; Rutherford, N.; Hofman, M.; Martin, A.; Stockler, M. R.; Davis, I. D. Share Save
Efficacy and safety of high-dose chemotherapy as second or subsequent salvage therapy in relapsed or refractory germ cell cancer patients: A multicentric analysis Seidel, C.; De Giorgi, U. F. F.; Engel, N.; Hentrich, M.; Zschaebitz, S.; Conolly, E.; Weickhardt, A. J.; Grimison, P.; Wong, V.; Oing, C.; Alsdorf, W.; Schaefers, C.; Bokemeyer, C.; Tran, B. Share Save
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial Tremblay, Samuel; Alhogbani, Mofarej; Weickhardt, Andrew; Davis, Ian D.; Scott, Andrew M.; Hicks, Rodney J.; Metser, Ur; Chua, Sue; Davda, Reena; Punwani, Shonit; Payne, Heather; Tunariu, Nina; Ho, Bao; Young, Sympascho; Singbo, Mahukpe Narcisse Ulrich; Bauman, Glenn; Emmett, Louise; Pouliot, Frederic Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
